Dr. Ronald Rubenstein

DDS | Dentist



  
  1525 E 53rd St, Suite 908, Chicago
  Illinois, 60615-4557

  773-667-9200    Maps & Directions
Dr. Ronald Rubenstein is a Chicago, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1525 E 53rd St, Suite 908, Chicago. Patients can reach him at 773-667-9200.
Dr. Ronald Rubenstein is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Ronald Rubenstein speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Ronald Rubenstein
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:1525 E 53rd St, Suite 908, Chicago,
Illinois, 60615-4557
Phone:773-667-9200
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 5092014720
Enrollment ID: I20160901001428
NPI Number: 1306927686
NPI Enumeration Date: 17 Oct, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 1525 E 53rd St, Suite 908
Chicago, Illinois
Zip: 60615-4557
Phone Number: 773-667-9200
Patients can reach Dr. Ronald Rubenstein at 1525 E 53rd St, Suite 908, Chicago, Illinois or can call to book an appointment on 773-667-9200. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: